Jo Jewell Announces Novartis Foundation and Novo Nordisk Collaboration
Jo Jewell, Director, Head of Social Responsibility Partnerships at Novo Nordisk, shared on LinkedIn:
”We’re excited to see the Novartis Foundation and Novo Nordisk join forces to tackle cardiometabolic risk in cities.
Our new collaboration will combine insights and proven approaches from the two leading urban health programmes CARDIO 4 Cities (Novartis Foundation and Cities for Better Health (Novo Nordisk).
Initially launching in two European capitals, the goal is to build scalable models using practical tools, real-time data and catalytic funding to scale prevention and strengthen health systems in many more cities.
By working together, our collaboration has the potential to create lasting impact on urban health and social inequities.
Learn more:
Stay updated with Hemostasis Today.
-
Apr 30, 2026, 14:09Robert Lufkin: Anti-Amyloid Drugs Fail Alzheimer’s Patients
-
Apr 30, 2026, 13:54Matthew D. Neal: A Major Step Forward in Trauma and Resuscitation Science
-
Apr 30, 2026, 13:35Day 2 of the EHC Youth Leadership Workshop 2026
-
Apr 30, 2026, 13:23The Gap Between Clinical Assessment and Patient Experience in VTE – RPTH Journal
-
Apr 30, 2026, 13:17Low Absolute Neutrophil Count Doesn’t Always Indicate Pathology – ASH Education
-
Apr 30, 2026, 13:01William Aird: When Inducers Make DOACs Fail
-
Apr 30, 2026, 12:56Abdul Muqtadir Abbasi: HIT Management – Avoid Platelet Transfusion
-
Apr 30, 2026, 12:45Chokri Ben Lamine: Methemoglobinemia in Hematology – Causes, Diagnosis, Antidote
-
Apr 30, 2026, 08:11Navya Sree: Breaking Down DVT From Theory to Practice